Abstract
The detailed analysis of β-amyloid (Aβ) peptides in human plasma is still hampered by the limited sensitivity of available mass spectrometric methods and the lack of appropiate ELISAs to measure Aβ peptides other than Aβ1-38, Aβ1-40, and Aβ1-42. By combining high-yield Aβ immunoprecipitation (IP), IEF, and urea-based Aβ-SDS-PAGE-immunoblot, at least 30 Aβ-immunoreactive spots were detected in human plasma samples as small as 1.6 mL. This approach clearly resolved Aβ peptides Aβ1-40, Aβ1-42, Aβ1-37, Aβ1-38, Aβ1-39, the N-truncated Aβ2-40, Aβ2-42, and, for the first time, also Aβ1-41. Relative quantification indicated that Aβ1-40 and Aβ1-42 accounted for less than 60% of the total amount of Aβ peptides in plasma. All other Aβ peptides appear to be either C-terminally or N-terminally truncated forms or as yet uncharacterized Aβ species which migrated as trains of spots with distinct pIs. The Aβ pattern found in cerebrospinal fluid (CSF) was substantially less complex. This sensitive method (2-D Aβ-WIB) might help clarifying the origin of distinct Aβ species from different tissues, cell types, or intracellular pools as well as their amyloidogenicity. It might further help identifying plasma Aβ species suitable as biomarkers for the diagnosis of Alzheimer's disease (AD).
| Original language | English |
|---|---|
| Pages (from-to) | 3815-3820 |
| Number of pages | 6 |
| Journal | Proteomics |
| Volume | 7 |
| Issue number | 20 |
| DOIs | |
| State | Published - Oct 2007 |
| Externally published | Yes |
Keywords
- Alzheimer's disease
- Aβ peptides
- Beta-amyloid
- Biomarker
- Plasma
Fingerprint
Dive into the research topics of 'Urea-based two-dimensional electrophoresis of beta-amyloid peptides in human plasma: Evidence for novel Aβ species'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver